Skip to main content
Clinical Trials/DRKS00030512
DRKS00030512
Active, not recruiting
未知

MRI examination of the breast in the context of BI-RADS 3 findings requiring control 6 months after initial pre-operative breast MRI - Ma-MRT_MagTrace

niversitätsklinikum Tübingen0 sites5 target enrollmentOctober 13, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
C50
Sponsor
niversitätsklinikum Tübingen
Enrollment
5
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2022
End Date
March 6, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversitätsklinikum Tübingen

Eligibility Criteria

Inclusion Criteria

  • Punch biopsy confirmed unifocal breast carcinoma,
  • \- Age \>50 years,
  • \- Written informed consent of the patient.

Exclusion Criteria

  • \- Multifocal or bilateral breast carcinoma,
  • \- Hereditary breast carcinoma, such as BRCA1/2,
  • \- Contrast agent allergy,
  • \- Contraindication for MRI.

Outcomes

Primary Outcomes

Not specified

Similar Trials